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Abstract Four novel cationic lipids with different numbers of
oxyethylene units at the linkage region between the pseudogly-
ceryl backbone and the hydrocarbon chains have been synthe-
sized and used as mixtures with 1,2-dioleoyl-L-K-glycero-3-
phosphatidyl ethanolamine (DOPE) for liposome-mediated gene
transfection. Incorporation of different numbers of oxyethylene
(^CH2CH2O^) units between long hydrocarbon chain at the C-1
and C-2 positions of the pseudoglyceryl skeleton improved the
transfection efficiency considerably compared to the one in which
the chains were connected via simple ether links. A pronounced
improvement in the gene transfer efficiency was observed with the
unsymmetrical cationic lipid 3 in which the long hydrocarbon at
the C-1 position of the pseudoglyceryl segment is connected via
two (^CH2CH2O^) units. Notably, the transfection ability of
lipid 3 with DOPE in the presence of serum was significantly
greater than LIPOFECTAMINE0. This suggests that introduc-
tion of oxyethylene units between long hydrocarbon chains at the
C-1 and C-2 positions of the pseudoglyceryl skeleton provides a
novel strategy to achieve efficient gene transfer, especially in
conditions where the presence of serum is critical. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
Ever since its discovery [1], cationic lipid-mediated gene
delivery remains at the forefront of present day scienti¢c re-
search owing to its possible applications in the ¢eld of gene
therapy. Even though the virus-mediated gene transfer is more
e⁄cient compared to lipofection, in vivo applications involv-
ing viral delivery matrices are limited due to the inherent
problems associated with it. As a consequence, cationic lipid
formulations have emerged as useful DNA delivery systems
due to their ease of large scale production, simplicity in
preparation and administration, acceptable levels of toxicity,
and low immunogenicity [2]. Combination methods taking
advantages of both viral and non-viral methods are also
very promising [3,4]. To improve the e⁄ciency of lipofection,
it is important to ¢ne-tune the various steps involved in trans-
fection starting from the complexation of the DNA with a
suitable cationic lipid to the ¢nal expression of the required
gene [5,6].
The linkage between the polar headgroup and hydrophobic
segments within a lipid molecule has been shown to in£uence
its aggregation property [7]. The aggregation behavior may
also play a role in mediating gene transfer events [8]. For
instance, N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammo-
nium chloride (DOTMA), which contains an ether linkage
between the trimethyl ammonium head group and the long
alkyl chains is shown to have much greater in vivo transfec-
tion e⁄ciency than the corresponding cationic lipid with an
ester linkage (DOTAP) [9]. Phospholipid derivatives with
polyoxyethylene (^CH2CH2O^)n groups in their head group
region have been shown to increase the particle stability of
small unilamellar phosphatidylcholine liposomes in plasma by
reducing its interaction with various macromolecules and cell
surfaces [10]. Incorporation of such lipids into cationic lipo-
somes led to enhanced stability of its complex with plasmid
DNA [11]. However, nothing is known with regard to the
transfection abilities of liposomes derived from cationic lipids
that bear one or more oxyethylene (^CH2CH2O^) units at the
chain backbone region. To address this issue with a new cat-
ionic lipid family, we have now synthesized a series of novel
cationic lipids (1^4) in which the linkage between the glycerol
backbone and the long hydrocarbon chain has been system-
atically modi¢ed with the insertion of oxyethylene units of
various lengths. Since the introduction of such linkers should
progressively alter the extent of lipid hydration at the interface
region, we thought that it might be important to understand
how these changes in lipid hydration and aggregation in£u-
ence the plasmid DNA delivery e⁄ciency inside the cell. It
was observed that lipids bearing oxyethylene groups at the
linkage region (lipids 1^4) were generally more active than
the lipid having just one ether linkage (DHTMA) in delivering
DNA inside the cell in vitro. The lipid having two oxyethylene
units at the C-1 chain linkage region (lipid 3) was found to be
the most e⁄cient cytofectin among the lipids studied when
used as a 1:1 formulation with helper lipid 1,2-dioleoyl-sn-
glycero-3-phosphatidylethanloamine (DOPE). Most impor-
tantly, the transfection e⁄ciency of these lipid formulations
was particularly impressive even when serum was present dur-
ing the DNA complexation.
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2. Materials and methods
2.1. Materials
DOPE was purchased from Avanti Polar Lipids. Commercially
available transfection reagent LIPOFECTAMINE0 was obtained
from Gibco BRL (USA). The cationic lipids 1^4, shown in Fig. 1,
have already been synthesized [12].
2.2. Plasmid DNA
Plasmid pEFGP-N1 (Clontech, USA), which encodes for an en-
hanced green £uorescence protein (GFP) under a CMV promoter,
was ampli¢ed in Escherichia coli (DH5K) and puri¢ed using Qiagen
Maxi Prep Plasmid Puri¢cation protocol (Qiagen, Germany). Purity
of the plasmid was checked by electrophoresis on 0.8% agarose gel
and was found to be more than 80% supercoiled. Concentration of the
DNA was estimated spectroscopically by measuring the absorption at
260 nm.
2.3. Liposome preparation
Individual cationic lipid or its mixture with DOPE in the desired
mol ratio was dissolved in chloroform in autoclaved Wheaton glass
vials. Thin ¢lms were made by evaporating the organic solvent under
a steady stream of dry nitrogen. Last traces of organic solvent were
removed by keeping these ¢lms under vacuum overnight. Freshly
autoclaved Water (Milli-Q) was added to individual ¢lm such that
¢nal concentration of the cationic lipid was 1 mM. The mixtures
were kept for hydration at 4‡C for V10 h and were repeatedly
freeze^thawed (ice-cold water to 50‡C) with intermittent vortexing
to ensure hydration. Sonication of these suspensions in a bath soni-
cator above the phase transition temperature of the lipids for 10^15
min a¡orded closed cationic liposomes as evidenced from transmis-
sion electron microscopy (not shown). Liposomes were prepared and
kept under strictly sterile conditions. Formulations were stable and if
stored frozen, possessed long shelf life.
2.4. Cell culture
HeLa cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
(DMEM; Gibco BRL, USA) supplemented with 10% fetal bovine
serum (FBS) in T25 culture £asks (Nunc, Denmark) and were incu-
bated at 37‡C in a humidi¢ed atmosphere containing 5% CO2. Cells
were regularly passaged by trypsinization with 0.1% trypsin (EDTA
0.02%, dextrose 0.05%, and trypsin 0.1%) in PBS (pH 7.2).
2.5. Cytotoxicity
Toxicity of each cationic lipid formulation with or without DOPE
toward HeLa cells in the presence of 10% FBS was determined using
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide reduc-
tion assay following literature procedures [13,14].
2.6. Transfection procedure
All transfection experiments were carried out in antibiotic-free me-
dia. In a typical experiment, 96-well plates were seeded with 9000
cells/well in antibiotic-free DMEM 24 h before transfection such
that they were V70% con£uent at the time of transfection. For trans-
fection in the absence of serum, lipid formulation and DNA were
serially diluted separately in DMEM containing no serum to have
the required working stocks. DNA was used at a concentration of
0.1 Wg/well. The lipid and DNA were complexed in a volume of 20 Wl
by incubating them together at room temperature for about 30 min.
The lipid concentrations were varied so as to obtain the required lipid/
DNA charge ratios of 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8 and 2.0. Charge
ratios here represent the ratio of charge on cationic lipid (in mol) to
nucleotide base molarity and were calculated by considering the aver-
age nucleotide mass of 330. After 30 min of complexation, 50 Wl of
medium was added to the complexes (¢nal DNA concentration = 4.33
WM). Old medium was removed from the wells and lipid^DNA com-
plexes in 70 Wl media were added to the cells. The plates were then
incubated for 5 h at 37‡C in a humidi¢ed atmosphere containing 5%
CO2. At the end of the incubation period, 130 Wl of DMEM contain-
ing 15.4% FBS was added per well such that ¢nal serum concentration
in the medium was 10%. Plates were further incubated for a period of
43 h before checking for the reporter gene expression. GFP expression
was estimated by £uorescent microscopy and was quanti¢ed by £ow
cytometry analysis. Control transfections were performed in each case
by using commercially available transfection reagent LIP-
OFECTAMINE0 with the same concentration of DNA using the
standard conditions speci¢ed by the manufacturer. All the experi-
ments were done in duplicates and the results presented are the aver-
age of at least four such independent experiments.
For transfections in which complexation was performed in the ab-
sence of serum but incubation in presence of serum, lipid and DNA
were separately diluted in serum-free media as already mentioned and
the complexation was done in serum-free media (20 Wl) for 30 min.
The complex was then diluted to 70 Wl with DMEM containing 14%
FBS so as to achieve a ¢nal serum concentration of 10%. The cells
were then incubated with this complex for 5 h. At the end of the
incubation period, 130 Wl of DMEM containing 10% FBS was added
and further incubated for 43 h as described earlier.
For transfections in which the complexation as well as the incuba-
tion was done in the presence of serum, the experiments were per-
formed as described earlier using medium containing 10% FBS for all
the steps involved in transfection.
2.6.1. Gel electrophoresis. To examine the complexation of DNA
with cationic lipid suspensions in the presence or absence of DOPE at
di¡erent lipid^DNA ratios, we prepared lipid^DNA complexes at
di¡erent lipid^DNA charge ratios in an identical manner as was
done with the transfection experiments. After 30 min of incubation,
these complexes were electrophoretically run on a 0.8% agarose gel.
The uncomplexed DNA moved out of the well but the DNA that was
complexed with lipid remained inside the well [15].
2.7. Flow cytometry
The reporter gene expression was examined by £uorescence micros-
copy at regular intervals and was quanti¢ed 48 h post-transfection by
£ow cytometry. Percentage of transfected cells was obtained by deter-
mining the statistics of cells £uorescing above the control level where-
in non-transfected cells were used as the control. Approximately
10 000 cells were analyzed to achieve the statistical data, which have
been presented as the average of at least four independent measure-
ments. For £ow cytometry analysis, V48 h post-transfection, old
medium was removed from the wells; cells were washed with PBS
and trypsinized by adding 25 Wl of 0.1% trypsin. To each well 200
Wl of PBS containing 20% FBS were added. Duplicate cultures were
pooled and analyzed by £ow cytometry immediately using Becton and
Dickinson £ow cytometer equipped with a ¢xed laser source at 488
nm.
3. Results
3.1. Transfection e⁄ciency of pEGFP-N1 plasmid DNA
Closed liposomes could be conveniently prepared from each
lipid (1^4) and with DOPE by ¢rst subjecting the ¢lms of the
individual lipid or their mixtures to hydration, then repeated
freeze^thaw cycles followed by sonication in aqueous bu¡er.
All the cationic lipid (1^4)-based formulations having an oxy-
ethylene group at the linkage were found to be capable of
delivering DNA inside the cell. In contrast, the control lipid
(DHTMA) possessing a single ether linkage between the pseu-
doglyceryl backbone and each hydrocarbon chain did not
Fig. 1. Chemical structures of various cationic lipids used in the
present study.
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show any transfection capabilities. Transfection abilities of the
neat lipid suspensions (1^4) were rather moderate when com-
pared with the commercially available transfecting agent LIP-
OFECTAMINE0 (not shown). Naturally occurring lipids
such as DOPE and cholesterol have been shown to increase
the e⁄ciency of transfection in lipid-mediated gene transfer
applications [1,5,16,17]. It may be noted that the positive con-
trol LIPOFECTAMINE0 reagent also contains DOPE in its
formulation. In order to ¢nd out the most e¡ective formula-
tion in the present instance, transfections were also performed
with varying amounts of helper lipids as mixed liposomal
formulation. While cholesterol had minimal e¡ects in enhanc-
ing the transfection e⁄ciency with these lipids, the inclusion
of DOPE dramatically increased the e⁄ciency of gene trans-
fer. At 1:1 DOPE/cationic lipid mol ratio, best transfection
e⁄ciencies were observed and such mixtures were used in all
further experiments. No free DNA was observed on the aga-
rose gel at a charge ratio of V1.2 (cationic lipid/DNA), sug-
gesting a saturation of DNA complexation by cationic lipids.
Maximal transfections were usually seen at this or at slightly
higher charge ratios in which the complete complexation oc-
curred and the transfection e⁄ciency followed a bell-shaped
dependency on lipid concentration as reported earlier with
other formulations (Fig. 4) [5].
One of the serious limitations of the cationic lipid-mediated
gene delivery, especially involving in vivo trials, is that the
transfection is ine⁄cient particularly in the presence of serum
proteins. For instance LIPOFECTAMINE0, an excellent
commercially available reagent for achieving in vitro trans-
fection is virtually ine¡ective in the presence of serum. Trans-
fections in the absence of serum even for in vitro experiments
are also cumbersome due to increased toxicity of synthetic
cationic lipid formulations. To have better potential especially
in gene therapy, it is important to have reagents that are
capable of delivering and expressing an external gene inside
a cell in the presence of serum. To have a clear understanding
of the e¡ect of serum in the presently described cationic lipid-
mediated gene delivery, transfections were performed under
the following three di¡erent conditions: (a) complexation
(30 min) and incubation (5 h) in the total absence of serum
(3fbs 3fbs conditions); (b) complexation (30 min) in the
absence of serum but incubation (5 h) in the presence of
10% FBS containing DMEM (3fbs +fbs conditions) ; and
(c) both complexation and incubation in the presence of
DMEM containing 10% FBS (+fbs +fbs conditions).
3.1.1. Complexation and incubation in the total absence of
serum. Comparison of the optimal transfection e⁄ciencies in
the absence of serum revealed that lipid 3, which possessed
two oxyethylene units at the linkage region of the C-1 chain
was the most e¡ective one among the lipids studied (Fig. 2).
The number of cells getting transfected using this lipid for-
mulation was comparable to LIPOFECTAMINE0 under
identical transfection conditions.
3.1.2. Complexation in the absence of serum and incubation
in the presence of DMEM containing 10% FBS. When serum
was present during the incubation period of 5 h, the trans-
fection e⁄ciency of LIPOFECTAMINE0 was reduced to
V20% of its e⁄ciency in the absence of serum. Notably how-
ever, no signi¢cant loss in transfection e⁄ciency was observed
in the case of presently described lipid (1^4)-based formula-
tions under this condition. A substantially higher population
of cells was found to be transfected when these synthetic lipid
formulations were used for transfection when compared with
LIPOFECTAMINE0(Fig. 3 and 4). The formulation, lipid
3+DOPE (1:1 mol ratio) was found to be the most e¡ective
transfecting agent. With this formulation, the number of cells
transfected was at least four times more than that of the LIP-
OFECTAMINE0.
3.1.3. E¡ect of complexation and incubation in the presence
10% FBS. The transfection ability of LIPOFECTAMINE0
was almost completely lost when serum was present in the
medium during DNA^lipid complexation. Practically no £uo-
rescent cells due to expressed GFP could be detected. With
the present set of cationic lipid formulations, however, no
considerable loss in transfection e⁄ciencies was observed in
the presence of serum irrespective of whether it was present
during complexation step or not (Fig. 5). Independent experi-
ment to probe DNA^lipid complexation using gel electropho-
resis suggested that lipid^DNA complexation was not a¡ected
signi¢cantly with these cationic lipid/DOPE formulations even
if serum was present during DNA^lipid complexation.
3.2. Cytotoxicity
With all the cationic lipid-based formulations (Fig. 1), the
cell viability was found to be more than 80% in the range of
concentration used for transfection experiments. ID50 (con-
centration that caused 50% cell death) values of the liposomal
suspensions of lipids 1^4 were V190, 75, 175 and 195 WM
respectively. For DHTMA, the ID50 value was higher than
the range studied (s 500 WM). LIPOFECTAMINE0 under
the same conditions as used for transfection showed a cell
viability of V75%. All the ID50 values were much higher
than the range of concentration in which a typical transfection
experiment was performed (i.e. V5 WM). Incorporation of the
helper lipid did not alter the cytotoxicity of the lipid formu-
lations signi¢cantly.
4. Discussion
In this paper we introduce some new cationic lipid-based
DNA transfection reagents. These lipids possess oxyethylene
linkages between the pseudoglyceryl backbone and long alkyl
chains of the lipid. These lipids form liposomes, which re-
mained intact for several months. The lipids bearing non-scis-
sile ether-based links are hydrolytically insensitive. Moreover,
the alkyl chains in these lipids are saturated, making them
Fig. 2. Optimal transfection e⁄ciencies the lipid (1^4)/DOPE formu-
lations (1:1) for pEGFP-N1 plasmid DNA in the total absence of
serum in comparison with LIPOFECTAMINE0.
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oxidatively and photochemically stable, a feature which often
renders most commercially available formulations based on
lipids bearing unsaturated hydrocarbon chains unsatisfactory.
The introduction of a variable number of oxyethylene units at
the linkage region signi¢cantly modi¢ed the aggregation prop-
erties of the resulting lipid suspensions [18]. It was also man-
ifested in their ability to deliver the DNA inside the mamma-
lian cell and its ability to induce e⁄cient expression. When the
number of oxyethylene linkages were increased, a substantial
increase in toxicity was observed with a concomitant decrease
in transfection e⁄ciency. Interestingly, the transfection e⁄-
ciencies were higher when there was a mismatch in the hydro-
phobic tail region of the lipid. The most e¡ective lipid was
found to be the one in which the oxyethylene group was
present only on C-1 chain of the lipid (lipid 3). Due to mis-
match in the chain lengths and chain backbone linkage region,
this lipid would assemble in a rather ‘disorganized’ manner in
its membranous aggregate. Recently, it was demonstrated that
such local disorders in the cell membrane might aid for the
e⁄cient delivery of the DNA inside the cell [19]. The trans-
fection studies further showed that in the case of this class of
lipids, the number of cells getting transfected were very high
and was often even higher than that of commercially available
reagent LIPOFECTAMINE0. These lipids also showed better
transfection e⁄ciency in the presence of serum. DOPE as a
helper lipid at a mol% of 50 was found to be the best for
transfection, while inclusion of cholesterol did not potentiate
transfection. Lipid 3 with DOPE at 1:1 mol ratio was found
to be the most e⁄cient formulation for DNA delivery among
the lipids studied. It was able to transfect comparable number
of cells with that of the commercial reagent LIP-
OFECTAMINE0 in the absence of serum. In the presence
of serum this lipid formulation was much better than the
commercial reagent. Transfection e⁄ciencies of the lipid for-
mulation were not a¡ected even when serum was present at
the complexation step. This suggests that the DNA complexes
of these lipid formulations are not a¡ected by serum. Work is
also underway to examine the generality of the above obser-
vations in other cell lines.
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